Abstract:Emerging evidence indicates that Ca 2+ is a vital factor in modulating the pathogenesis of Alzheimer's disease (AD). In healthy neurons, Ca 2+ concentration is balanced to maintain a lower level in the cytosol than in the extracellular space or certain intracellular compartments such as endoplasmic reticulum (ER) and the lysosome, whereas this homeostasis is broken in AD. On the plasma membrane, the AD hallmarks amyloid-β (Aβ) and tau interact with ligand-gated or voltage-gated Ca 2+ -influx channels and inhibit the Ca 2+ -efflux ATPase or exchangers, leading to an elevated intracellular Ca 2+ level and disrupted Ca 2+ signal. In the ER, the disabled presenilin "Ca 2+ leak" function and the direct implications of Aβ and presenilin mutants contribute to Ca 2+ -signal disorder. The enhanced ryanodine receptor (RyR)–mediated and inositol 1,4,5-trisphosphate receptor (IP 3 R)–mediated Ca 2+ release from the ER aggravates cytosolic Ca 2+ disorder and triggers apoptosis; the down-regulated ER Ca 2+ sensor, stromal interaction molecule (STIM), alleviates store-operated Ca 2+ entry in plasma membrane, leading to spine loss. The increased transfer of Ca 2+ from ER to mitochondria through mitochondria-associated ER membrane (MAM) causes Ca 2+ overload in the mitochondrial matrix and consequently opens the cellular damage-related channel, mitochondrial permeability transition pore (mPTP). In this review, we discuss the effects of Aβ, tau and presenilin on neuronal Ca 2+ signal, focusing on the receptors and regulators in plasma membrane and ER; we briefly introduce the involvement of MAM-mediated Ca 2+ transfer and mPTP opening in AD pathogenesis.—Wang, X., Zheng, W. Ca 2+ homeostasis dysregulation in Alzheimer's disease: a focus on plasma membrane and cell organelles.

[Calcium Dyshomeostasis and Alzheimer's Disease]

Effect of intraperitoneal pentobarbital injection or isoflurane inhalation anesthesia on the rat acute stress response

Progress in molecular mechanisms of β-amyloid peptides in alzheimer's disease

Calcium Signaling Regulated by Cellular Membrane Systems and Calcium Homeostasis Perturbed in Alzheimer’s Disease

Calcium dysregulation in Alzheimer's disease: from mechanisms to therapeutic opportunities.

Calcium Dyshomeostasis in Alzheimer’s Disease Pathogenesis

Ca2+ homeostasis dysregulation in Alzheimer's disease: a focus on plasma membrane and cell organelles

Elevating the Levels of Calcium Ions Exacerbate Alzheimer’s Disease via Inducing the Production and Aggregation of β-Amyloid Protein and Phosphorylated Tau

Mitochondria and Calcium in Alzheimer’s Disease: From Cell Signaling to Neuronal Cell Death

The Complex Interplay between Toxic Hallmark Proteins, Calmodulin-Binding Proteins, Ion Channels, and Receptors Involved in Calcium Dyshomeostasis in Neurodegeneration

Deregulation of Brain Insulin Signaling in Alzheimer’s Disease

Functional interplay between plasma membrane Ca2+-ATPase, amyloid β-peptide and tau

Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease

Role of Cholinergic Signaling in Alzheimer’s Disease

Mitochondrial Calcium Deregulation in the Mechanism of Beta-Amyloid and Tau Pathology

Overview of the Molecular Modalities and Signaling Pathways Intersecting with β-Amyloid and Tau Protein in Alzheimer’s Disease

The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases

Metals homeostasis and related proteins in alzheimer's disease

The Role of Cholesterol Metabolism in Alzheimer’s Disease

Microvascular and cellular dysfunctions in Alzheimer's disease: an integrative analysis perspective

Roles of O-GlcNAcylation on amyloid-β precursor protein processing, tau phosphorylation, and hippocampal synapses dysfunction in Alzheimer’s disease